Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Sell
29
CIM Quote, Financials, Valuation and Earnings
Last price:
$14.17
Seasonality move
:
-2.69%
Day range:
$14.22 - $14.45
52-week range:
$11.29 - $16.89
Dividend yield:
9.66%
P/E ratio:
4.30x
P/S ratio:
2.75x
P/B ratio:
0.42x
Volume:
486.8K
Avg. volume:
493.9K
1-year change:
-10.53%
Market cap:
$1.2B
Revenue:
$204.8M
EPS (TTM):
$3.32
Analysts' Opinion
-
Consensus RatingChimera Investment has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Chimera Investment has an estimated upside of 12.05% from its current price of $14.28.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $14.28.
Fair Value
-
According to the consensus of 0 analysts, Chimera Investment has 12.05% upside to fair value with a price target of -- per share.
CIM vs. S&P 500
-
Over the past 5 trading days, Chimera Investment has underperformed the S&P 500 by -1.42% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Chimera Investment does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Chimera Investment has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Chimera Investment reported revenues of $152M.
Earnings Growth
-
Chimera Investment has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Chimera Investment reported earnings per share of $1.39.
Enterprise value:
11.8B
EV / Invested capital:
0.88x
Price / LTM sales:
2.75x
EV / EBIT:
13.90x
EV / Revenue:
28.12x
PEG ratio (5yr expected):
0.04x
EV / Free cash flow:
59.32x
Price / Operating cash flow:
5.81x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.71%
Net Income Margin (TTM):
84.09%
Return On Equity:
13.5%
Return On Invested Capital:
2.76%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -$507.2M | $285.6M | $419.9M | $18.1M | $152M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$8.55 | $1.51 | $3.32 | -$0.22 | $1.39 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $412.4M | $402.5M | $174.1M | $211.4M | $174.4M | |
| Total Assets | $18.1B | $16B | $13.7B | $12.9B | $13.7B | |
| Current Liabilities | $727.4M | $298.2M | $733.8M | $91.8M | $197.7M | |
| Total Liabilities | $14.4B | $12.2B | $11B | $10.4B | $11B | |
| Total Equity | $3.7B | $3.8B | $2.7B | $2.5B | $2.7B | |
| Total Debt | $13.6B | $11.8B | $10.3B | $10.3B | $10.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $408.4M | $208.4M | $199M | $44.7M | $41.4M | |
| Cash From Investing | $1.4B | $29.3M | -$134.6M | $367.9M | -$646.2M | |
| Cash From Financing | -$2B | -$185.3M | -$105.7M | -$474.9M | $539.8M | |
| Free Cash Flow | $408.4M | $208.4M | $199M | $44.7M | $41.4M | |
CIM
Sector
Market Cap
$1.2B
$698.9M
Price % of 52-Week High
84.55%
88.68%
Dividend Yield
9.66%
2.18%
Shareholder Yield
--
3.87%
1-Year Price Total Return
-10.53%
7.42%
Beta (5-Year)
1.710
0.734
Dividend yield:
9.66%
Annualized payout:
$2.10
Payout ratio:
60.64%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$14.45
200-day SMA
Buy
Level
$14.18
Bollinger Bands (100)
Sell
Level
14.61 - 15.75
Chaikin Money Flow
Buy
Level
354.3M
20-day SMA
Sell
Level
$14.71
Relative Strength Index (RSI14)
Sell
Level
39.47
ADX Line
Sell
Level
27.19
Williams %R
Neutral
Level
-71.4673
50-day SMA
Sell
Level
$14.99
MACD (12, 26)
Sell
Level
-0.18
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Sell
Level
-375.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.0358)
Sell
CA Score
(Annual)
Level (-1.6266)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.1742)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
Stock Forecast FAQ
In the current month, CIM has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CIM average analyst price target in the past 3 months is --.
-
Where Will Chimera Investment Stock Be In 1 Year?
According to analysts, the consensus estimate is that Chimera Investment share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Chimera Investment?
Analysts are divided on their view about Chimera Investment share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Chimera Investment is a Sell and believe this share price will drop from its current level to --.
-
What Is Chimera Investment's Price Target?
The price target for Chimera Investment over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CIM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Chimera Investment is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CIM?
You can purchase shares of Chimera Investment via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Chimera Investment shares.
-
What Is The Chimera Investment Share Price Today?
Chimera Investment was last trading at $14.17 per share. This represents the most recent stock quote for Chimera Investment. Yesterday, Chimera Investment closed at $14.28 per share.
-
How To Buy Chimera Investment Stock Online?
In order to purchase Chimera Investment stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
